HealthcareChina
NHSA: Drug Company Forged Doctor Letters in Procurement
China's NHSA reveals a drug company forged 80% of doctor signatures in a letter to influence drug procurement. Novartis and Takeda deny involvement.
—4 min read
Tag
#Drug Procurement
2 articles
HealthcareEconomy
China Drug Procurement: From Lowest Price to Clinical Value
China's 12th drug procurement round shifts focus to clinical value, with anti-involution measures and a revival mechanism for originator drugs.
—4 min read